Study Shows Topical BioPharmX Formulation Treats Acne While Minimizing Systemic Exposure of Minocycline
BioPharmX Corporation, a specialty pharmaceutical company, announced that research being presented at the 2016 Winter Clinical Dermatology Conference shows its unique formulation of minocycline, known as BPX-01, may offer a...
Read More
